Through our unique DSE strain technology, we aim to enable the cost-effective cultivation of plants in increasingly degraded environments (such as soil acidification, salinization, and rising temperatures). This improves farmers' operations while addressing broader challenges, including food security, soil and forest restoration, and environmental sustainability.
Company Details
- Employees
- 4
- Founded
- 2024
- Address
- 1-3-11 Fujimi, Chiyoda-Ku,tokyo 102-0071,japan
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://endo-phyte.com/
- Keywords
- Symbiobe.
- HQ
- Chiyoda-ku, Tokyo
Endophyte, Inc. Questions
Endophyte, Inc.'s website is https://endo-phyte.com/
Endophyte, Inc.'s LinkedIn profile is https://jp.linkedin.com/company/endophyte-inc
Endophyte, Inc. has
4 employees.
View email and phone details for 4
employees at Endophyte, Inc..
Endophyte, Inc.'s industry is
Biotechnology Research
Endophyte, Inc.'s top competitors are
Clinical Research Advancement,
株式会社アイメックｒｄ,
Ac-Planta Inc.,
エムスリーマーケティング株式会社,
Elith Inc.,
Endophyte,
Endophyto,
リクロマ株式会社,
Coupa Japan,
Symbiobe.
Endophyte, Inc.'s categories are Biotechnology Research
Endophyte, Inc.'s founding year is 2024
